Credit Suisse October 21, 2021
Jailendra Singh, Carlos Consuegra, Adam Heussner, Jay Jin

  • OSH/RubiconMD Transaction Underscores Digital Health Consolidation Theme. This morning, OSH (Not Covered) acquired RubiconMD (see our note on RubiconMD for a detailed overview) for $130M in cash, with the sellers having an opportunity to earn up to another $60M dependent on performance milestones, including low integration costs. OSH’s announcement comes during a period in which many Digital Health/HCIT companies have made strategic M&A a priority. With digital connectivity becoming the main highway for care pathways, several companies/industries need a different level of scalability, reliability, and comprehensiveness. The digital health solutions landscape is highly fragmented, and the continuing consolidation should enable digital health vendors to obtain the scale and efficiencies required to succeed in the emerging healthcare paradigm. In this...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Market Research, Technology, Trends
The distressed HealthTech M&A landscape in 2025
Where do the opportunities exist in today's distressed HealthTech M&A landscape in the UK?
Implementation Science: from niche discipline to growing role, influence and future in Healthcare Technology
The Winning Edge: Can Virtual Health Make a Profit?
100+ organizations ask Trump administration to make telehealth controlled substance prescribing permanent

Share This Article